Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Torrent Pharmaceuticals Ltd

TORNTPHARM.NS ✓ COMPLIANT ☆ Track — members

NSE India · Healthcare · Pharmaceuticals ·

India Large Cap Analyst: BUY

Last Close

$50.64

▼ -1.66%

Market Cap $19.26B · Vol 166.89K

Key Metrics

P/E Ratio

77.21

FWD: 62.03

Market Cap

$19.26B

Large Cap

Div Yield

0.79%

Semi-annual dividend

EPS Growth

+4.45%

YoY

RSI (14)

37.48

Momentum

Beta

0.62

vs Market

52W High

$55.01

8.05% below

52W Low

$36.47

29.13% above

Volume

166.89K

Avg 765.71K

P/B

16.98

Price-to-book

ROE

28.19%

Return on equity

Free Float

36.58%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Torrent Pharmaceuticals Ltd (TORNTPHARM.NS) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does TORNTPHARM.NS pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-1.85%

-2.82%

+9.74%

+18.51%

YTD

+25.53%

+33.40%

+113.58%

+227.89%

Financials & Valuation

TTM · Annual

Total Revenue	$1.50B
Net Income	$228.79M
Revenue Growth (YoY)	+54.85%
Gross Margin	66.78%
Operating Margin	24.61%
Net Profit Margin	15.29%
ROE	28.19%
ROA · ROIC	9.69% · 11.28%

P/E Ratio	77.21
Forward P/E (FY1)	62.03
PEG Ratio	5.00
P/S	10.22
P/B	16.98
P/FCF	73.10
EPS Growth	+4.45%
Outstanding Shares	380.37M

Technical Indicators

50-Day SMA	$50.06
200-Day SMA	$44.38
RSI (14)	37.48
Beta	0.62
52-Week High	$55.01
52-Week Low	$36.47

Volume Today	166.89K
Avg Daily Volume (30D)	765.71K
Relative Volume	0.22x
Volatility (10D)	9.98
Volatility (30D)	28.24
Free Float	36.58%

Analyst Consensus

BUY

Current Price $50.64

Mean Target $55.50

52W Low$36.47 52W High$55.01

Current

Target

$36.47 $55.01

Current Analyst target

+9.61% upside potential · 32 analysts

Identifiers

ExchangeNSE India

FIGIBBG001S862M4

ISININE685A01028

CountryIndia

Sub-IndustryPharmaceuticals (NEC)

Earnings DateNov 5, 2026

TypeStocks

Instrument TypeFULLPAID Fully Paid Ordinary

Similar Halal Stocks

LLY Eli Lilly and Co -2.39% JNJ Johnson & Johnson -0.66% ABBV Abbvie Inc -0.54% NVS Novartis AG -0.55% NOVN.S Novartis AG -1.05%

Company Profile

Torrent Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is engaged in research, development, manufacturing, marketing and distribution of branded and generic pharmaceutical formulations in India and internationally. The Company is focused on various therapeutic segments, such as cardiovascular (CV), central nervous system (CNS), gastrointestinal (GI), vitamins minerals nutrients (VMN), anti-diabetes (AD), pain management, gynecology, and dermatology. Its pediatric product brands include Tedibar, Atogla, Spoo and B4 Nappi. Its Anti-diabetic products include Gliclazide 80 mg, Tablets, Gliclazide 30 mg, Tablets, Glimepiride 1, 2, 3, 4 mg, Tablets, and others. Its dermatologic therapy products include Macrotor, Ahaglow S Facewash, Fungicide Lotion, Hairjoy 2%, New Dewsoft Cream, Lookbrite 20GMS, Cortaz NC, Dermanex, and others. Its manufacturing facilities are located in the states of Gujarat, Himachal Pradesh, Madhya Pradesh, Andhra Pradesh and Sikkim.